Citadel Advisors
USNA icon

Citadel Advisors’s Usana Health Sciences USNA Stock Holding History

Citadel Advisors’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$357K Buy
16,700
+6,600
+65% +$124K ﹤0.01% 10710
2026
Q1 		$176K Sell
10,100
-2,700
-21% -$53.6K ﹤0.01% 11540
2025
Q4 		$251K Sell
12,800
-100
-0.8% -$2.08K ﹤0.01% 10541
2025
Q3 		$355K Buy
+12,900
New +$397K ﹤0.01% 9955
2025
Q2 		– Sell
-7,200
Closed -$194K – 15228
2025
Q1 		$194K Buy
7,200
+5,100
+243% +$161K ﹤0.01% 10499
2024
Q4 		$75.4K Sell
2,100
-700
-25% -$26.2K ﹤0.01% 11862
2024
Q3 		$106K Buy
2,800
+100
+4% +$4.11K ﹤0.01% 11025
2024
Q2 		$122K Sell
2,700
-7,100
-72% -$327K ﹤0.01% 10635
2024
Q1 		$475K Buy
9,800
+9,300
+1,860% +$455K ﹤0.01% 8520
2023
Q4 		$26.8K Sell
500
-1,000
-67% -$50.6K ﹤0.01% 12365
2023
Q3 		$87.9K Buy
1,500
+800
+114% +$50K ﹤0.01% 11053
2023
Q2 		$44.1K Sell
700
-10,900
-94% -$694K ﹤0.01% 11951
2023
Q1 		$730K Buy
11,600
+8,500
+274% +$507K ﹤0.01% 7472
2022
Q4 		$165K Buy
+3,100
New +$168K ﹤0.01% 10455
2021
Q4 		– Sell
-3,800
Closed -$350K – 14803
2021
Q3 		$350K Sell
3,800
-1,500
-28% -$144K ﹤0.01% 10718
2021
Q2 		$543K Buy
5,300
+500
+10% +$50.2K ﹤0.01% 9893
2021
Q1 		$468K Buy
4,800
+1,400
+41% +$127K ﹤0.01% 9816
2020
Q4 		$262K Buy
+3,400
New +$263K ﹤0.01% 9302
2020
Q3 		– Sell
-4,700
Closed -$345K – 10774
2020
Q2 		$345K Sell
4,700
-4,500
-49% -$353K ﹤0.01% 7690
2020
Q1 		$531K Buy
9,200
+4,500
+96% +$313K ﹤0.01% 6373
2019
Q4 		$369K Sell
4,700
-500
-10% -$36.8K ﹤0.01% 7269
2019
Q3 		$356K Buy
5,200
+2,100
+68% +$141K ﹤0.01% 7310
2019
Q2 		$246K Buy
+3,100
New +$246K ﹤0.01% 7893
2019
Q1 		– Sell
-3,000
Closed -$353K – 9894
2018
Q4 		$353K Sell
3,000
-100
-3% -$11.6K ﹤0.01% 6982
2018
Q3 		$374K Sell
3,100
-3,200
-51% -$397K ﹤0.01% 7206
2018
Q2 		$726K Buy
+6,300
New +$689K ﹤0.01% 5763

Other funds holding USNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors's USNA Position: Q2 2026 in Review

Citadel Advisors reduced its Usana Health Sciences (USNA) stake by 34% in Q2 2026, selling an estimated $267K and leaving 26,961 shares worth $576K. The position accounts for ﹤0.01% of the portfolio, ranked #9520.

Citadel Advisors first reported a position in USNA in Q2 2013 and has held it in 46 quarters since. The position peaked at $13.8M in Q1 2019. 138 funds tracked by Wall St. Rank hold USNA as of Q2 2026.

  • Citadel Advisors held 26,961 shares of Usana Health Sciences worth $576K as of Q2 2026.
  • Citadel Advisors sold 14,187 Usana Health Sciences shares in Q2 2026, an estimated $267K.
  • Usana Health Sciences made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #9520 holding.
  • Citadel Advisors first reported a position in Usana Health Sciences in Q2 2013 and has held it in 46 quarters since.
  • Citadel Advisors's Usana Health Sciences position peaked at $13.8M in Q1 2019.
  • 138 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.